Supplementary Figure S4 from Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S4. Dose-Normalized CC-90011 Parameters by Dose Level. Box plots of dose-normalized AUC0-168 (A) and Cmax (B) after day 1 dosing. Boxes represent the interquartile range, white horizontal lines indicate the median, and open circles represent individual values. AUC0-168, area under the plasma concentration-time curve from time 0 to 168 hours; Cmax, maximum plasma drug concentration. Data cutoff: 3 May 2019.
Authors: Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Nicolas Isambert, Patricia Niccoli, Jaume Capdevila, Giuseppe Curigliano, Victor Moreno, Patricia Martin-Romano, Eric Baudin, Marina Arias, Sheila Mora, Juan de Alvaro, Jorge Di Martino, Josep L. Parra-Palau, Tania Sánchez-Pérez, Ida Aronchik, Ellen H. Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S. de Bono
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361938264